Glimfirst MV 1mg/500mg/0.2mg Tablet SR
Marketer
Sinsan Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimfirst MV 1mg/500mg/0.2mg Tablet SR
Glimfirst MV 1mg/500mg/0.2mg Tablet SR, an antidiabetic medication, combines multiple agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Administer this extended-release tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuing without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect. Learn to recognize its symptoms—sweating, dizziness, headache, tremor—and how to counteract it. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice. Regular blood glucose monitoring is necessary; additional blood tests to assess blood cell counts and liver function may be recommended.
Uses of Glimfirst MV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimfirst MV 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimfirst MV 1mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or fracture it. Administer on an empty stomach.
Common Side effects of Glimfirst MV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimfirst MV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Glimfirst MV 1mg/500mg/0.2mg Extended-Release Tablet should be taken on an empty stomach.
How Glimfirst MV 1mg/500mg/0.2mg Tablet SR works:
Glimfirst MV extended-release tablets (1mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimfirst MV 1mg/500mg/0.2mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Glimfirst MV 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimfirst MV tablets (1mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Glimfirst MV 1mg/500mg/0.2mg Tablet SR carries a high risk in individuals with kidney impairment and should be strictly avoided. Medical advice is essential. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimfirst MV 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced starting dose is typically advised for individuals with mild to moderate liver disease; its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimfirst MV 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glimfirst MV 1mg/500mg/0.2mg Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Glimfirst MV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently